期刊文献+

X-连锁肾上腺脑白质营养不良患者成纤维细胞系MnSOD基因表达增强 被引量:1

Gene expression of MnSOD in X-linked Adrenoleukodystrophy fibroblasts X-ALD murine model
下载PDF
导出
摘要 探讨X 连锁肾上腺脑白质营养不良 (X linkedAdrenoleukodystrophy,X ALD)个体的MnSOD表达的变化与发病机理的相关性。应用免疫组化、免疫荧光、定量PCR法 ,观察锰过氧化物岐化酶 (Mnactivatedsuperoxidedismutase ,MnSOD)表达的差异。免疫组化的结果显示X ALD小鼠脑组织中MnSOD的含量高于野生型小鼠 ;免疫荧光显示CCER(X ALD中最严重的一种 )患者成纤维细胞中的MnSOD含量高于健康人 ;定量PCR显示CCER患者成纤维细胞中MnSODmRNA量高于健康人 ,并且MnSOD能被 4PBA诱导。推测氧化应激升高可能是造成X ALD患者神经系统退行性改变的原因之一。而MnSOD增加则有助于细胞清除氧自由基 ,缓解氧化应激 ,为应用 4PBA治疗X These studies focus on the metabolic defect and pharmacological therapies of X linked adrenoleukodystrophy (X ALD). There are several indications that oxidative stress is likely to play a role in pathophysiology of X ALD. In this research, immunohistochemical studies showed that Mn activated superoxide dismutase (MnSOD) was increased in the brain of X ALD mouse. Immunofluorescent studies showed that there is more detectable MnSOD in fibroblasts from CCER (severe form of X ALD) patients and quantitative PCR showed that MnSOD mRNA was increased in fibroblasts from CCER patients and expression of MnSOD was induced by 4PBA. This is a first report that X ALD is associated with oxidative stress. Enhancing expression of MnSOD by 4PBA may be helpful to inner cellular environment amelioration and thus become an approach to treat X ALD.
出处 《基础医学与临床》 CSCD 北大核心 2003年第2期146-149,共4页 Basic and Clinical Medicine
基金 国家教委出国留学人员基金 (2 0 0 0 )
关键词 X-连锁肾上腺脑白质营养不良 成纤维细胞 MNSOD 基因表达 发病机理 隐性遗传代谢病 adrenoleukodystrophy oxidative stress Mn activated superoxide dismutase (MnSOD) 4 phenylbutyrate(4PBA)
  • 相关文献

参考文献2

  • 1Myriam Baes. Mouse models for peroxisome biogenesis disorders[J] 2000,Cell Biochemistry and Biophysics(1-3):229~237
  • 2Kirby D. Smith,Stephan Kemp,Lelita T. Braiterman,Jyh-Feng Lu,He-Ming Wei,Michael Geraghty,Gail Stetten,James S. Bergin,Jonathan Pevsner,Paul A. Watkins. X-Linked Adrenoleukodystrophy: Genes, Mutations, and Phenotypes[J] 1999,Neurochemical Research(4):521~535

同被引文献9

  • 1Moser HW. Adrenoleukodystrophy: pheuotype, genetics, pathogenesis and therapy. Brain, 1997,120(Pt 8) :1485-1508.
  • 2Girard S, Bruckert E, Turpin G. Endocrine disease in adrenoleukodystrophy. Ann Med Interne ( Paris), 2001,152:15-26.
  • 3郭爱丽.肾上腺皮质功能减退症[A].见:史轶蘩 主编.协和内分泌和代谢学[C].北京:科技出版社,1999.1135-1146.
  • 4Moser AB, Kreiter N. Bezman L, et al. Plasma very long chain fatty acids in 3000 peroxisome disease patients and 29000 controls. Ann Neurol, 1999,45: 100-110.
  • 5Aubourg P, Diebler C. Adrenoleukodystrophy-its diverse CT appearances and evolutive or phenotypic varient: the leukodystrophy without adrenal insufficiency. Neuroradiology, 1982,24:33-42.
  • 6Moser HW. Adrenoleukodystrophy: natural history. Inher Metab Dis,1995,18:435-447,
  • 7Kemp S, Pujol A, Waterham HR, et al. ABCD1 mutations and the Xlinked adrenoleukodystrophy mutation database: role in diagnosis and clinical correlations. Hum Mutat ( Paris), 2001,18:499-515.
  • 8Fuchs S, Sarde CO, Wedemann H, et al. Missense mutations are frequent in the gene for X-chromosomal adrenoleukodystrophy (ALD).Hum Mol Genet, 1994,3:1903-1905.
  • 9Stadtman E. Protein oxidation and aging. Science, 1992,257:1220-1224.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部